Table 1.

Differences between patients with and without IgG antibodies to SARS-CoV-2.

	IgG SARS-CoV-2 antibodies				p
	No		Yes
	37		24
	n	%	n	%
Gender*
Female	21	55	14	58	0.9
Male	16	45	10	42
Age group*
<18 years	10	27	10	42	0.9
>18 years	27	73	14	58
Evolution*
Ambulatory	23	62	9	38	0.2
Hospitalisation	14	38	15	63
SARS-CoV-2 severe	9	24	6	25	0.2
Endotracheal intubation	3	8	14	42	0.001
Time**	Median	p25–p75	Median	p25–p75
PCR positive (days)	29	(23–45)	18	(15–30)	0.01
Symptoms (days)	30	(25–37)	20	(15–42)	0.03
Symptoms (weeks)	1	(1–3)	3	(2–5)	0.002
Respiratory symptons	15	42	9	50	0.5
Fever > 3 weeks	9	25	11	57	0.01

^*X² test.

^**U Mann–Whitney. Bold values indicate statistical significance.